112 related articles for article (PubMed ID: 37080358)
1. Dose-dependent effects of zoledronic acid on the osteogenic differentiation of human bone marrow stem cells (hBMSCs).
Hadad H; Matheus HR; Chen JE; Jounaidi Y; Souza FÁ; Guastaldi FPS
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6):101479. PubMed ID: 37080358
[TBL] [Abstract][Full Text] [Related]
2. Bifunctional effect of Zoledronic Acid (ZA) on human mesenchymal stem cells (hMSCs) based on the concentration level.
Fliefel R; El Ashwah A; Entekhabi S; Kumbrink J; Ehrenfeld M; Otto S
J Stomatol Oral Maxillofac Surg; 2020 Dec; 121(6):634-641. PubMed ID: 32171967
[TBL] [Abstract][Full Text] [Related]
3. Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition.
Patntirapong S; Singhatanadgit W; Chanruangvanit C; Lavanrattanakul K; Satravaha Y
J Oral Pathol Med; 2012 Oct; 41(9):713-20. PubMed ID: 22563819
[TBL] [Abstract][Full Text] [Related]
4. Pulse treatment with zoledronic acid causes sustained commitment of bone marrow derived mesenchymal stem cells for osteogenic differentiation.
Ebert R; Zeck S; Krug R; Meissner-Weigl J; Schneider D; Seefried L; Eulert J; Jakob F
Bone; 2009 May; 44(5):858-64. PubMed ID: 19442618
[TBL] [Abstract][Full Text] [Related]
5. Pretreatment with Bisphosphonate Enhances Osteogenesis of Bone Marrow Mesenchymal Stem Cells.
Hu L; Wen Y; Xu J; Wu T; Zhang C; Wang J; Du J; Wang S
Stem Cells Dev; 2017 Jan; 26(2):123-132. PubMed ID: 27736364
[TBL] [Abstract][Full Text] [Related]
6. Osteoanabolic effect of alendronate and zoledronate on bone marrow stromal cells (BMSCs) isolated from aged female osteoporotic patients and its implications for their mode of action in the treatment of age-related bone loss.
Lindtner RA; Tiaden AN; Genelin K; Ebner HL; Manzl C; Klawitter M; Sitte I; von Rechenberg B; Blauth M; Richards PJ
Osteoporos Int; 2014 Mar; 25(3):1151-61. PubMed ID: 23974861
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
[TBL] [Abstract][Full Text] [Related]
8. Dose-Dependent Effects of Zoledronic Acid on Human Periodontal Ligament Stem Cells: An
Di Vito A; Chiarella E; Baudi F; Scardamaglia P; Antonelli A; Giudice D; Barni T; Fortunato L; Giudice A
Cell Transplant; 2020; 29():963689720948497. PubMed ID: 33086890
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
[TBL] [Abstract][Full Text] [Related]
10. Effects of miR-103 by negatively regulating SATB2 on proliferation and osteogenic differentiation of human bone marrow mesenchymal stem cells.
Lv H; Yang H; Wang Y
PLoS One; 2020; 15(5):e0232695. PubMed ID: 32379794
[TBL] [Abstract][Full Text] [Related]
11. [Effect of zoladronate on the proliferation and osteogenic differentiation of rat bone mesenchymal stem cells].
Li JH; Su ZF; Bai X; Yuan H; Li JY
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Jun; 37(3):242-247. PubMed ID: 31218855
[TBL] [Abstract][Full Text] [Related]
12. Super-Enhancer-Associated Long Non-Coding RNA LINC01485 Promotes Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells by Regulating MiR-619-5p/RUNX2 Axis.
Gu W; Jiang X; Wang W; Mujagond P; Liu J; Mai Z; Tang H; Li S; Xiao H; Zhao J
Front Endocrinol (Lausanne); 2022; 13():846154. PubMed ID: 35663324
[TBL] [Abstract][Full Text] [Related]
13. Histone H3K9 demethylase JMJD2B/KDM4B promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells by regulating H3K9me2 on RUNX2.
Kang P; Wu Z; Huang Y; Luo Z; Huo S; Chen Q
PeerJ; 2022; 10():e13862. PubMed ID: 36217382
[TBL] [Abstract][Full Text] [Related]
14. Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt/β-catenin signaling pathway.
Hang K; Ye C; Xu J; Chen E; Wang C; Zhang W; Ni L; Kuang Z; Ying L; Xue D; Pan Z
Stem Cell Res Ther; 2019 Jun; 10(1):189. PubMed ID: 31238979
[TBL] [Abstract][Full Text] [Related]
15. Teriparatide and the treatment of bisphosphonate-related osteonecrosis of the jaw: a rat model.
Ersan N; van Ruijven LJ; Bronckers AL; Olgaç V; Ilgüy D; Everts V
Dentomaxillofac Radiol; 2014; 43(1):20130144. PubMed ID: 24170800
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Effects of Systemic Zoledronic Acid Application on Bone Maturation in the Consolidation Period in Distraction Osteogenesis.
Akbulut Y; Gul M; Dundar S; Ozcan EC; Ozercan IH; Bozoglan A; Karasu N; Acikan I; Bingül MB
J Craniofac Surg; 2021 Nov-Dec 01; 32(8):2901-2905. PubMed ID: 33935139
[TBL] [Abstract][Full Text] [Related]
17. Zoledronic acid inhibits human osteoblast activities.
Basso FG; Silveira Turrioni AP; Hebling J; de Souza Costa CA
Gerontology; 2013; 59(6):534-41. PubMed ID: 23867757
[TBL] [Abstract][Full Text] [Related]
18. MiR-137 promotes TLR4/NF-κB pathway activity through targeting KDM4A, inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells and aggravates osteoporosis.
Yu YF; Yao PQ; Wang ZK; Xie WW
J Orthop Surg Res; 2023 Jun; 18(1):444. PubMed ID: 37344864
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of the osteogenic differentiation capacity of human bone marrow- and human adipose-derived stem cells under cyclic tensile stretch using quantitative analysis.
Ye Y; Du Y; Guo F; Gong C; Yang K; Qin L
Int J Mol Med; 2012 Dec; 30(6):1327-34. PubMed ID: 22961098
[TBL] [Abstract][Full Text] [Related]
20. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
Schindeler A; Little DG
Biochem Biophys Res Commun; 2005 Dec; 338(2):710-6. PubMed ID: 16243296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
